Myrtelle to Host Symposium on Gene Therapies Targeting Oligodendrocytes and Implications in Brain Function and Disease States at the American Society of Gene and Cell Therapy 26th Annual Meeting in Los Angeles on Friday, May 19, 2023
WAKEFIELD, Mass.--(BUSINESS WIRE)-- #AAV--Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, will host a symposium on the expanding understanding of oligodendrocytes in brain function and disease states at the American Society of Gene and Cell Therapy 26th Annual Meeting...
